111 related articles for article (PubMed ID: 3082748)
1. Evidence for the in vivo production and release into the serum of a T-cell lymphokine, persisting-cell stimulating factor (PSF), during graft-versus-host reactions.
Crapper RM; Schrader JW
Immunology; 1986 Apr; 57(4):553-8. PubMed ID: 3082748
[TBL] [Abstract][Full Text] [Related]
2. The in vivo functions and properties of persisting cell-stimulating factor.
Crapper RM; Clark-Lewis I; Schrader JW
Immunology; 1984 Sep; 53(1):33-42. PubMed ID: 6432685
[TBL] [Abstract][Full Text] [Related]
3. In vivo transfer of persisting (P) cells; further evidence for their identity with T-dependent mast cells.
Crapper RM; Thomas WR; Schrader JW
J Immunol; 1984 Oct; 133(4):2174-9. PubMed ID: 6432908
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the binding of a hemopoietic growth factor, P-cell-stimulating factor, to a cell surface receptor using quantitative absorption of bioactivity.
Crapper RM; Clark-Lewis I; Schrader JW
Exp Hematol; 1985 Oct; 13(9):941-7. PubMed ID: 2995104
[TBL] [Abstract][Full Text] [Related]
5. Reconstitution of lymphoid tissues under the influence of a subclinical level of graft versus host reaction induced by bone marrow T cells or splenic T cell subsets.
Hirano M; Arase H; Arase-Fukushi N; Ogasawara K; Iwabuchi K; Miyazaki T; Good RA; Onoé K
Cell Immunol; 1993 Oct; 151(1):118-32. PubMed ID: 8402923
[TBL] [Abstract][Full Text] [Related]
6. Evidence for two distinct mechanisms in acute fatal graft-versus-host reaction across minor histocompatibility barriers.
OKunewick JP; Buffo MJ; Kociban DL
Exp Hematol; 1987 May; 15(4):365-72. PubMed ID: 3494625
[TBL] [Abstract][Full Text] [Related]
7. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
[TBL] [Abstract][Full Text] [Related]
8. P cell stimulating factor and glucocorticoids oppose the action of interferon-gamma in inducing Ia antigens on T-dependent mast cells (P cells).
Wong GH; Clark-Lewis I; Hamilton JA; Schrader JW
J Immunol; 1984 Oct; 133(4):2043-50. PubMed ID: 6088631
[TBL] [Abstract][Full Text] [Related]
9. Demonstration and characterization of a serum factor produced by activated T cells.
Dardenne M; Bach JF
Immunology; 1977 Nov; 33(5):643-51. PubMed ID: 22486
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppressive activity of macrophages in mice undergoing graft-versus-host reaction due to major histocompatibility complex class I plus II difference.
Ikarashi Y; Kawai K; Watanabe H; Matsumoto Y; Omata S; Fujiwara M
Immunology; 1993 May; 79(1):95-102. PubMed ID: 8099568
[TBL] [Abstract][Full Text] [Related]
11. Recovery of T cell populations after acute graft-vs-host reaction.
Hakim FT; Payne S; Shearer GM
J Immunol; 1994 Jan; 152(1):58-64. PubMed ID: 8254206
[TBL] [Abstract][Full Text] [Related]
12. The graft-versus-host reaction and immune function. III. Functional pre-T cells in the bone marrow of graft-versus-host-reactive mice displaying T cell immunodeficiency.
Seddik M; Seemayer TA; Lapp WS
Transplantation; 1986 Feb; 41(2):238-42. PubMed ID: 3484849
[TBL] [Abstract][Full Text] [Related]
13. Alloimmunization-activated suppressor cells. I: Abrogation of lethal graft-versus-host reaction directed against non-H-2 antigens.
Halle-Pannenko O; Pritchard LL; Rappaport H
Transplantation; 1983 Jul; 36(1):60-8. PubMed ID: 6223422
[TBL] [Abstract][Full Text] [Related]
14. In vitro approaches to lymphopoiesis, hemopoiesis, and oncogenesis.
Schrader JW; Schrader S; Clark-Lewis I; Crapper R
Kroc Found Ser; 1984; 18():293-307. PubMed ID: 6152287
[TBL] [Abstract][Full Text] [Related]
15. Lymphokine activity production in graft-versus-host reactions across minor histocompatibility antigen barriers.
Hirokawa M; Takatsu H; Ohshima A; Chubachi A; Kudo K; Niitsu H; Takahashi T; Yoshida K; Miura AB
Clin Exp Immunol; 1989 Sep; 77(3):434-9. PubMed ID: 2530013
[TBL] [Abstract][Full Text] [Related]
16. Unexpected role of TNF-alpha in graft versus host reaction (GVHR): donor-derived TNF-alpha suppresses GVHR via inhibition of IFN-gamma-dependent donor type-1 immunity.
Yamamoto S; Tsuji T; Matsuzaki J; Zhange Y; Chamoto K; Kosaka A; Togashi Y; Sekikawa K; Sawada K; Takeshima T; Koike T; Nishimura T
Int Immunol; 2004 Jun; 16(6):811-7. PubMed ID: 15126416
[TBL] [Abstract][Full Text] [Related]
17. The local xenogeneic graft-versus-host reaction as a clinical test for immunocompetence of human T lymphocytes.
Shohat B; Trainin N
Thymus; 1980 Sep; 2(2):93-105. PubMed ID: 6969478
[TBL] [Abstract][Full Text] [Related]
18. Role of L3T4+ and Lyt-2+ donor cells in graft-versus-host immune deficiency induced across a class I, class II, or whole H-2 difference.
Moser M; Sharrow SO; Shearer GM
J Immunol; 1988 Apr; 140(8):2600-8. PubMed ID: 3258615
[TBL] [Abstract][Full Text] [Related]
19. A T cell-derived factor stimulating multipotential hemopoietic stem cells: molecular weight and distinction from T cell growth factor and T cell-derived granulocyte-macrophage colony-stimulating factor.
Schrader JW; Clark-Lewis I
J Immunol; 1982 Jul; 129(1):30-5. PubMed ID: 6979567
[TBL] [Abstract][Full Text] [Related]
20. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine.
Mowat AM; Ferguson A
Gastroenterology; 1982 Aug; 83(2):417-23. PubMed ID: 6979490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
